Latest filing published 02 Apr 2025 for BIODESIX INC.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Charles M. Watts: trading record in brief
Filings by Charles M. Watts span 2 companies, the busiest being Biodesix Inc and Accelerate Diagnostics, Inc. Between 30 October 2020 and 31 March 2025, the trades on record add up to 9 filings.
The open-market record is one-sided, with 3 purchases worth €102k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant and 5 option exercises.
The median purchase comes to €31k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 2 April 2025: an option exercise, in Biodesix Inc. The most recent open-market purchase was published on 21 November 2022, 1,450 days ago. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Charles M. Watts
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 46,686 sharesCommon StockSEC:0000905148-25-001048:0
- 26,368 sharesCommon StockSEC:0000905148-24-001920:0
- 134,262 sharesCommon StockSEC:0000905148-24-001076:0
- 12,345 shares@ US$1.6216.4% of flowCommon StockSEC:0000905148-23-000630:0
- 69,619 shares0Common StockSEC:0001628280-23-019989:0
- 150,711 sharesCommon StockSEC:0001140361-23-016257:0
- 43,478 shares@ US$1.1543.5% of flowCommon StockSEC:0001140361-22-042603:0Canonical exit: 19 Feb 2023 (T+90)
- 5,855 shares@ US$4.292425.1% of flowCommon StockSEC:0001567619-21-022443:0Canonical exit: 20 Mar 2022 (T+90)
8 of 8 declarations